For example, Sweet-Cordero et al. (2005) defined a KRAS induced lung cancer signature by comparing lung tumors generated from a spontaneous KRAS mutation mouse model to normal mouse lung tissue. This evidence concerns the gene KRAS and lung carcinoma.